Alerts

If you've purchased APOHEALTH Paracetamol Pain Relief paracetamol 500 mg film-coated tablets in a bottle, ensure it is kept out of reach of children. This product does not have child-resistant packaging.

Investigating the efficacy and safety of over-the-counter codeine containing combination analgesics for pain and codeine based antitussives

Consumers and health professionals should be aware that two unrelated cases of counterfeit injectable botulinum toxin products have been stopped at the Australian border.

Hazard alert - increased risk of heart attack and blood clot

Update - registered product now available

We are advising that Movectro (cladribine) has been withdrawn from supply in Australia due to commercial reasons.

Cybersecurity vulnerability from Apache Log4j

Recall - potential for over-delivery of insulin and risk of hypoglycaemia

Update - PBS changes and supplier letter reinforce prescribing guidance

In 2003, the TGA recalled Pan Pharmaceuticals’ products due to serious safety and manufacturing issues.

Consumers are advised not to purchase Bright Eyes products being offered for sale on the internet

Our safety advisory includes information for consumers and health professionals about low levels of nitrosamine impurity in medicines containing sitagliptin.

Rick's Hemp Oil Full Spectrum Hemp Supplement 500 mg poses a serious risk to your health and should not be taken.

Safety advisory - low levels of contamination with a nitrosamine impurity

TGA is issuing a safety advisory about the importation of unregistered GLP-1 products that are being promoted online for weight-loss.

Find out how we are investigating low levels of the nitrosamine impurity in medicines containing fluoxetine. Read information for consumers and health professionals.

Product Defect Alert - child-resistant caps may not function correctly

Advice for FMT providers on safety protections related to COVID-19

This review concerns the safety of use of codeine-containing products in children in the context of ultra-rapid metabolisers

Recall - potential for medicine to prematurely degrade during its shelf-life